CVR number 31860725
Industry 86.2100 General medical practice activities

LÆGE Tine Dreijer ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  3.3% 2.5% 3.4% 3.0% 4.9%  
Credit score (0-100)  55 60 54 57 45  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  2,924 2,712 2,700 2,941 2,416  
EBITDA  705 464 287 383 79.9  
EBIT  669 428 261 361 59.2  
Pre-tax profit (PTP)  617.3 390.8 238.0 349.2 44.1  
Net earnings  500.9 298.2 179.7 265.2 28.1  
Pre-tax profit without non-rec. items  617 391 238 349 44.1  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  1,458 1,422 1,442 1,420 1,399  
Shareholders equity total  1,461 1,646 1,711 1,859 1,765  
Interest-bearing liabilities  30.9 13.9 13.9 2.9 2.9  
Balance sheet total (assets)  2,706 2,701 2,235 2,363 2,248  
Net Debt  -990 -972 -573 -736 -624  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  -100.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,924 2,712 2,700 2,941 2,416  
Gross profit growth  13.2% -7.2% -0.4% 8.9% -17.8%  
Employees  5 4 4 4 4  
Employee growth %  0.0% -20.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,706 2,701 2,235 2,363 2,248  
Balance sheet change%  -22.5% -0.2% -17.3% 5.7% -4.9%  
Added value  704.6 464.3 287.0 387.0 79.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -884 -72 -6 -44 -42  
Net sales trend  -1.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  22.9% 15.8% 9.7% 12.3% 2.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  21.6% 15.8% 10.6% 15.7% 2.6%  
ROI %  25.4% 18.0% 12.5% 20.1% 3.3%  
ROE %  39.6% 19.2% 10.7% 14.9% 1.5%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  54.0% 60.9% 76.6% 78.7% 78.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -140.5% -209.3% -199.8% -192.0% -781.0%  
Gearing %  2.1% 0.8% 0.8% 0.2% 0.2%  
Net interest  0 0 0 0 0  
Financing costs %  10.0% 167.1% 166.7% 143.3% 519.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  2.9 5.0 3.5 4.7 4.7  
Current Ratio  2.9 5.0 3.5 4.7 4.7  
Cash and cash equivalent  1,020.6 985.7 587.3 739.0 627.2  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  820.0 1,024.2 569.5 741.9 668.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  141 116 72 97 20  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  141 116 72 96 20  
EBIT / employee  134 107 65 90 15  
Net earnings / employee  100 75 45 66 7